birb 796 has been researched along with as1940477 in 1 studies
Studies (birb 796) | Trials (birb 796) | Recent Studies (post-2010) (birb 796) | Studies (as1940477) | Trials (as1940477) | Recent Studies (post-2010) (as1940477) |
---|---|---|---|---|---|
137 | 5 | 80 | 5 | 0 | 5 |
Protein | Taxonomy | birb 796 (IC50) | as1940477 (IC50) |
---|---|---|---|
Mitogen-activated protein kinase 13 | Homo sapiens (human) | 0.011 | |
Fatty-acid amide hydrolase 1 | Rattus norvegicus (Norway rat) | 0.036 | |
Mitogen-activated protein kinase 11 | Homo sapiens (human) | 0.036 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asano, T; Harayama, Y; Kasahara, C; Kinoshita, T; Kontani, T; Kubota, H; Misumi, K; Mizuhara, H; Ohno, K; Ohta, M; Takeuchi, M; Yamazaki, H; Yokomoto, M | 1 |
1 other study(ies) available for birb 796 and as1940477
Article | Year |
---|---|
Identification, synthesis, and biological evaluation of 6-[(6R)-2-(4-fluorophenyl)-6-(hydroxymethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3(2H)-one (AS1940477), a potent p38 MAP kinase inhibitor.
Topics: Biological Availability; Humans; Magnetic Resonance Spectroscopy; Mass Spectrometry; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors | 2012 |